FROM:
Molecular and phenotypic characterization of human amniotic fluid cells and their differentiation potential
Patrizia Bossolasco, Tiziana Montemurro, Lidia Cova, Stefano Zangrossi, Cinzia Calzarossa, Simona Buiatiotis, Davide Soligo, Silvano Bosari, Vincenzo Silani, Giorgio Lambertenghi Deliliers, Paolo Rebulla and Lorenza Lazzari
BACK TO ARTICLE| Marker | Before treatments | After treatments |
|---|---|---|
| MyoD | - | - |
| Myogenin | - | - |
| Desmin | <5% | - |
| Actin | - | nd |
| CD133 | <5% | - |
| Nestin | 100% | nd |
| SH2 | 80% | nd |
| CD45 | - | nd |
| CD34 | - | nd |
| TE7 | 70% | nd |
| NGFR | <0.1% | nd |
| CD44 | 100% | nd |
| NCAM | - | nd |
| AE1/AE3 | 99% | nd |
| O4 | - | nd |
| GFAP | 54% | 70% |
| beta tubulin III | 89% | 95% |
Results are expressed as percentage of positive cells on the total number of counted cells; negative results (-); not done (nd).
